Inscription Capital’s Hologic HOLX Stock Holding History

Inscription Capital’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,528	Closed	-$342K	–	824
2026 Q1	$342K	Sell	4,528 -3,256	-42%	-$245K	0.04%	457
2025 Q4	$580K	Buy	7,784 +81	+1%	+$5.92K	0.06%	320
2025 Q3	$520K	Buy	7,703 +2,505	+48%	+$166K	0.06%	343
2025 Q2	$339K	Buy	+5,198	New	+$312K	0.05%	323
2021 Q3	–	Sell	-5,500	Closed	-$367K	–	286
2021 Q2	$367K	Buy	+5,500	New	+$368K	0.04%	226

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Inscription Capital's HOLX Position: Q2 2026 in Review

Inscription Capital sold out of Hologic (HOLX) in Q2 2026, closing a stake of 4,528 shares — an estimated $342K sold.

Inscription Capital first reported a position in HOLX in Q2 2021 and held it in 5 quarters. The position peaked at $580K in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Inscription Capital reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Inscription Capital sold 4,528 Hologic shares in Q2 2026, an estimated $342K.
Inscription Capital first reported a position in Hologic in Q2 2021 and held it in 5 quarters.
Inscription Capital's Hologic position peaked at $580K in Q4 2025.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.